Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: Report of a case

Surgery Today

Volumn 42, Issue 2, 2012, Pages 200-204

  Sumiyoshi, Tatsuaki ^a   Moriguchi, Michihisa ^a   Kanemoto, Hideyuki ^a   Asakura, Kouiku ^a   Sasaki, Keiko ^a   Sugiura, Teiichi ^a   Mizuno, Takashi ^a   Uesaka, Katsuhiko ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Diffuse fatty change; Hepatocellular adenoma; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOXETIC ACID;

ADULT; ARTICLE; CASE REPORT; CHOLECYSTECTOMY; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ADENOMA, LIVER CELL; ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857641926     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-011-0067-7     Document Type: Article

References (26)

1. S Dokmak V Paradis V Vilgrain A Sauvanet O Farges 2009 A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas Gastroenterology 137 1698 1705 19664629 10.1053/j.gastro.2009.07.061
2. K Hasegawa N Kokudo 2009 Surgical treatment of hepatocellular carcinoma Surg Today 39 833 843 19784720 10.1007/s00595-008-4024-z
3. AK Lim N Patel WM Gedroyc MJ Blomley G Hamilton 2002 Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques Br J Radiol 75 695 699 12153946 1:STN:280:DC%2BD38vjsFWqsg%3D%3D
4. T Ichikawa MP Federle L Grazioli M Nalesnik 2000 Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients Radiology 214 861 868 10715059 1:STN:280:DC%2BD3c7osV2nug%3D%3D (Pubitemid 30115393)
5. D Delbeke WH Martin MP Sandler WC Chapman JK Wright Jr CW Pinson 1998 Evaluation of benign vs malignant hepatic lesions with positron emission tomography Arch Surg 133 510 515 9605913 10.1001/archsurg.133.5.510 1:STN:280:DyaK1c3ms12msg%3D%3D (Pubitemid 28224319)
6. T Torizuka N Tamaki T Inokuma Y Magata S Sasayama 1995 In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET J Nucl Med 36 1811 1817 7562048 1:STN:280:DyaK28%2FgslKgsw%3D%3D
7. Seo S, Hatano E, Higashi T, Hara T, Tada M. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res. 2007;13:427-3.
8. JP Zeng JH Dong WZ Zhang J Wang XP Pang 2010 Hepatic angiomyolipoma: a clinical experience in diagnosis and treatment Dig Dis Sci 55 3235 3240 20165978 10.1007/s10620-010-1144-2
9. ZD Goodman UV Mikel PR Lubbers PR Ros JM Langloss 1987 Kupffer cells in hepatocellular adenomas Am J Surg Pathol 11 191 196 3030147 10.1097/00000478- 198703000-00003 1:STN:280:DyaL2s7lsVSrug%3D%3D (Pubitemid 17040457)
10. RG Beets-Tan JM Van Engelshoven JW Greve 1998 Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI Clin Imaging 22 211 215 9559234 10.1016/S0899-7071(97)00117-4 1:STN:280:DyaK1c3hvF2rug%3D%3D (Pubitemid 28176770)
11. R Kuwatsuru RC Brasch A Mühler A Mathur VS Vexler W Rosenau, et al. 1997 Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents Radiology 202 131 138 8988202 1:STN:280:DyaK2s7ktF2msA%3D%3D (Pubitemid 27024118)
12. Nakano K, Tsushima Y, Shibuya K, Miyazaki M, Koyama Y, Amanuma M, et al. A case of focal fatty liver, which showed hypointensity in the hepatobiliary phase of MR imaging with Gd-EOB-DTPA. Jpn J Clin Radiol. 2010;55:460-4 (in Japanese).
13. SS Ahn MJ Kim JS Lim HS Hong YE Chung 2010 Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma Radiology 255 459 466 20413759 10.1148/radiol.10091388
14. Maeda A, Uesaka K, Matsunaga K, Hideyuki K, Noriyoshi F, Naoki M. Well differentiated hepatocellular carcinoma, 35 mm in diameter with remarkable fatty change, mimicking an angiomyolipoma on diagnostic images-a case report. Jpn J Gastroenterol Surg. 2005;38:1439-44 (in Japanese). (Pubitemid 41353798)
15. R Kutami Y Nakashima O Nakashima K Shiota M Kojiro 2000 Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans J Hepatol 33 282 289 10952246 10.1016/S0168-8278(00)80369-4 1:STN:280:DC%2BD3M%2Fks1aqsA%3D%3D (Pubitemid 30485232)
16. 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases Ann Oncol 9 397 401 9636830 10.1023/A:1008290027419 1:STN:280:DyaK1czgtVCmuw%3D%3D (Pubitemid 28273032)
17. G Magini M Farsad M Frigerio C Serra A Colecchia E Jovine, et al. 2009 C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma Clin Nucl Med 34 659 665 19893396 10.1097/RLU.0b013e3181b53488
18. PM Patel H Alibazoglu A Ali E Fordham G LaMonica 1997 "False-positive" uptake of FDG in a hepatic adenoma Clin Nucl Med 22 490 491 9227877 10.1097/00003072-199707000-00012 1:STN:280:DyaK2szntFKlsQ%3D%3D (Pubitemid 28069022)
19. 18F-FDG PET detection of colonic adenomas J Nucl Med 42 989 992 11438616 1:STN:280:DC%2BD3MzotVyqsg%3D%3D (Pubitemid 32595293)
20. K Kubota K Ito M Morooka T Mitsumoto K Kurihara H Yamashita, et al. 2009 Whole-body FDG-PET/CT on rheumatoid arthritis of large joints Ann Nucl Med 23 783 791 19834653 10.1007/s12149-009-0305-x
21. S Nishizawa M Inubushi A Kido M Miyagawa T Inoue K Shinohara, et al. 2008 Incidence and characteristics of uterine leiomyomas with FDG uptake Ann Nucl Med 22 803 810 19039559 10.1007/s12149-008-0184-6
22. J Zucman-Rossi E Jeannot JT Nhieu JY Scoazec C Guettier 2006 Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC Hepatology 43 515 524 16496320 10.1002/hep.21068 1:CAS:528:DC%2BD28XjtVKqsbc%3D
23. P Bioulac-Sage JF Blanc S Rebouissou C Balabaud J Zucman-Rossi 2007 Genotype phenotype classification of hepatocellular adenoma World J Gastroenterol 13 2649 2654 17569132 1:CAS:528:DC%2BD2sXotFyku74%3D (Pubitemid 46958719)
24. P Bioulac-Sage S Rebouissou C Thomas JF Blanc J Saric 2007 Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry Hepatology 46 740 748 17663417 10.1002/hep.21743 1:CAS:528:DC%2BD2sXhtFWhsr3F (Pubitemid 47436120)
25. H Laumonier P Bioulac-Sage C Laurent J Zucman-Rossi C Balabaud 2008 Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification Hepatology 48 808 818 18688875 10.1002/hep.22417
26. P Bioulac-Sage H Laumonier G Couchy B Le Bail A Sa Cunha 2009 Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience Hepatology 50 481 489 19585623 10.1002/hep.22995